Article
Clonal architecture predicts clinical outcomes and drug sensitivity in acute myeloid leukemia.
Nature communications - 13 Dec 2021
Benard Brooks A, Leak Logan B, Azizi Armon, Thomas Daniel, Gentles Andrew J, Majeti Ravindra
Abstract excerpt
The impact of clonal heterogeneity on disease behavior or drug response in acute myeloid leukemia remains poorly understood. Using a cohort of 2,829 patients, we identify features of clonality associated with clinical features and drug sensitivities. High variant allele frequency for 7 mutations (including NRAS and TET2) associate with dismal prognosis; elevated GATA2 variant allele frequency correlates with...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
